ABSTRACT

The pharmaceutical industry relies on CROs for a variety of services. The process also makes it possible for companies to conduct clinical trials in challenging conditions as part of the drug development process. These types of organizations are classified into two categories: clinical and preclinical. Phase 0 and Phase I centers, as well as clinical trials, would constitute clinical services. A corporate strategy, including CROs, was developed in the mid-1990s to touch, over 1100 CROs (of which 30 percent are non-clinical and 70 percent are clinical) may be found globally. In the early phases of their drug pipelines, pharmaceutical firms are increasingly utilizing a functional outsourcing strategy. To bring this to fruition and meet market demand, while also helping to improve the country's economic standards and position in the market, the government, industry, and business professionals must collaborate on legal affairs, inspections, visibility in work affairs, and earning patient trust, and safety monitoring. Keywords: Pharmaceutical industry, Contract Research Organization (CRO), Research organization, Drug development, Business support services
Publication date: 01/08/2023

https://ijbpas.com/pdf/2023/August/MS_IJBPAS_2023_7332.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2023/12.8.7332